Charles River Laboratories International (CRL) Gross Profit (2016 - 2025)
Historic Gross Profit for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $432.2 million.
- Charles River Laboratories International's Gross Profit fell 200.58% to $432.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 1738.82%. This contributed to the annual value of $1.7 billion for FY2024, which is 704.79% down from last year.
- Latest data reveals that Charles River Laboratories International reported Gross Profit of $432.2 million as of Q3 2025, which was down 200.58% from $447.3 million recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Gross Profit registered a high of $695.0 million during Q4 2023, and its lowest value of $361.8 million during Q3 2023.
- For the 5-year period, Charles River Laboratories International's Gross Profit averaged around $440.0 million, with its median value being $433.4 million (2024).
- As far as peak fluctuations go, Charles River Laboratories International's Gross Profit soared by 4232.1% in 2021, and later plummeted by 4517.43% in 2024.
- Quarter analysis of 5 years shows Charles River Laboratories International's Gross Profit stood at $437.0 million in 2021, then increased by 13.68% to $496.7 million in 2022, then soared by 39.91% to $695.0 million in 2023, then crashed by 45.17% to $381.0 million in 2024, then grew by 13.44% to $432.2 million in 2025.
- Its last three reported values are $432.2 million in Q3 2025, $447.3 million for Q2 2025, and $406.7 million during Q1 2025.